ABOUT US
We strive to improve the patient’s ability to take control of their own mental health
We explore experimental therapies that go beyond traditional health care.
WHAT WE DO
Mind Therapeutics conducts QEEG and ERP clinical trials with our advanced biotechnology data collection process.
We focus on anxiety, depression, addiction, sleeping disorders and PTSD as the mental health crisis has exploded in recent years.
Our industry-leading neuroscientist and medical experts are poised to transform the standard of care for mental health.
Media
Our Results:
Our clinical research may allow us to transcend current methodologies, lower costs as we increase access for valuable treatments, and establish new standards for mental health care.
Mission
We aim to explore all the possibilities of care for the health of the mind using advanced brain scan technology and industry-leading expertise. We will work openly and look to improve the outlook for mental health to improve the lives of those in need.
Leadership
Katarina Maloney
Chief Executive Officer
Katarina is a biotechnology leader in business development, strategic operations, supply chain, and product management. She completed two simultaneous bachelor’s degrees in European Studies/Political Science and Foreign Language. She attended leadership programs at Cornell University and Crescom Leadership Training Institute and is experienced in the hemp and cannabis industries.
Bernard Wandernoth, PhD
Chief Engineering Officer
Mrs. Wandernoth is a Switzerland signals engineer of Human Brain Interface (HBI) brain wave database and the EEG and ERP hardware and software system for QEEG and ERP analysis and has extensive international experience in compliance and regulations.
Partnerships
83BarGo is our recruitment agency that finds appropriate clinical trial subjects using a simple and thorough online system. They will track the data for all subjects throughout the trial and will even follow-up with subjects long-term. This is an important part of our clinical studies to fully optimize the data and research.
COEUS Consulting Group maximizes our brand success and product access with their expert insight into customer decision-making. They are experts in pharmaceutical product brands and have innovative methods to employ customer engagement to educate on disease burden, therapy, and quality of care. Their health economics and market specialists and have launched an extensive number of products and have managed the lifecycle of their portfolio offerings. COEUS offers actionable insights and is important as we develop our drugs and gain market support.
We will be using psilocybin plant genome in our trials to ensure quality, keep costs low, and help benefit the environment. Cellibre helps us to provide pharmaceutical grade products that we can track with VeChain during all phases of clinical and FDA trials. We can compare profiles and outcomes of traditionally grown to cell-based genome and find the best use of our products. We favor agricultural plant science as a system that promotes environmental preservation while securing quality.
CereScan, CereMetrix, and CereLaw offer quantitative SPECT imaging and brain analytics and combine their data with their database of conditions and subjects. They include neuroradiological reports with 3 dimensional images that pick up what MRI and CT scans usually miss. CereScan analyses the data of the sub-regions of the basal ganglia, blood flow, and a full assessment of the brain. We can provide a specific treatment plan with these incredible brain measurements.
Clinlogix provides clinical research support that integrates technology in our clinical trials. They will track subjects using lifetime, crossover, and combination therapy studies. Clinlogix works with a highly regarded network of medical and scientific advisors that enables them to carry out quality research and full-scale clinical trials. Their partnership with clinical specialisits ensures proper assessment of symptoms and neurological conditions and supports proper therapeutics and enrollment in the neurology studies. They have extensive market experience and understand complex biopharmaceutical goods in order to develop quality products.
VeChain allows us to show patients, consumers, and the public market every step of the supply chain to promote transparency and accountability. We want complete visibility during clinical trials to ensure quality and safety by showing the medicines we are using, how they impact the mental health of patients, and showing end-to-end tracking of production. It is also important to gain traction with legalization efforts.
Join Our study
We at Mind Therapeutics are united by our commitment to improve patient experience and healing in mental health care.
Below is a submission link to join our study for those who are experiencing Anxiety, Depression,PTSD and Addiction and looking for alternative, experimental therapies.
Investors
Join us by investing in our journey to improve mental
health and happiness. Sign up for regular updates,
press releases, and announcements that are
delivered right to your inbox.
Newsletter
Join our Healing Community by signing up for a newsletter to receive the latest news and updates of our work and discoveries.
